Clinical and Laboratory Observations
Calderwood, Stanley MD*,‡; Sabir, Aqsa MD*,‡; Rao, Latha MD†,‡; Baker, Brian MLS, JD‡; Balasa, Vinod MD†,‡,§; Sathi, Bindu K. MD†,‡,§
*Pediatric Hospital Medicine Program, Bakersfield Memorial Hospital, Bakersfield
†Pediatric Hematology Oncology
‡Valley Children’s Healthcare, Madera
§University of San Francisco—Fresno Program, Fresno, CA
Some parts of this article have been presented at the American Society of Pediatric Hematology Oncology annual meeting, 2021.
B.K.S. receives funding from the Center for Inherited Blood Disorders (P0547992).
B.K.S. is a consultant for Vertex pharmaceuticals. V.B. serves a speaker for CSL Behring, Sanofi Genzyme, and Takeda. The remaining authors declare no conflict of interest.
Reprints: Bindu K. Sathi, MD, Department of Pediatric Hematology Oncology, Valley Children’s Hospital, University of California San Francisco—Fresno Program, 9300 Valley Children’s Place, Madera, CA 93636 (e-mail: [email protected]).
